[Hepatorenal syndrome: a new therapeutic approach?].
Gerbes
A L
AL
Medizinische Klinik II, Klinikum Grosshadern, München.
Gülberg
V
V
D004359:Drug Therapy, Combination; D006530:Hepatorenal Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007677:Kidney Function Tests; D008879:Midodrine / Q000008:administration & dosage*; D015282:Octreotide / Q000008:administration & dosage*; D012709:Serum Albumin / Q000008:administration & dosage; D015996:Survival Rate; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D012709:Serum Albumin; D014662:Vasoconstrictor Agents; D008879:Midodrine; D015282:Octreotide